The DOI matches its Crossref record.
Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias
Abstract
Summary . Congenital neutropenias include a heterogenous group of diseases characterized by a decrease in circulating neutrophils. In phase I/II/III studies in patients with severe congenital and cyclic neutropenia, treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) resulted in a rise in the absolute neutrophil counts (ANC) and a reduction in infections. We report the effects of long‐term safety of subcutaneous r‐metHuG‐CSF administration in 54 patients (congenital n= 44, cyclic n= 10) treated for 4–6 years. A sustained ANC response was seen in 40/44 severe congenital neutropenia patients and 10/10 cyclic neutropenia patients. Two patients required an increase of > 25% in dose to maintain a clinical response; one patient became refractory to therapy. A significant decrease in the incidence of severe infections and the need for intravenous antibiotics was noted. Significant adverse events noted which may or may not be related to therapy included: osteopenia (n= 15), splenomegaly (n= 12), hypersplenism (n= 1), vasculitis (n= 2), glomerulonephritis (n= 1), BM fibrosis (n= 2), MDS/leukaemia (n= 3), and transient inverted chromosome 5q with excess blasts (n= 1). R‐metHuG‐CSF has been well tolerated in the majority of patients and resulted in a longterm improvement in their clinical status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Filgrastim (r-metHuG-CSF): the first 10 years
Welte, K., Gabrilove, J., Bronchud, M., Platzer, E., & Morstyn, G. (1996) · Blood · doi:10.1182/blood.v88.6.1907.bloodjournal8861907 · Cited by 599
Self-citationDong, F., Brynes, R. K., Tidow, N., Welte, K., Löwenberg, B., & Touw, I. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330804 · Cited by 449
Self-citationSevere congenital neutropenias
Skokowa, J., Dale, D. C., Touw, I. P., Zeidler, C., & Welte, K. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.32 · Cited by 383
Self-citationDale, D. C., Cottle, T. E., Fier, C. J., Bolyard, A. A., Bonilla, M. A., Boxer, L. A., Cham, B., Freedman, M. H., Kannourakis, G., Kinsey, S. E., et al. (2003) · American Journal of Hematology · doi:10.1002/ajh.10255 · Cited by 374
Self-citationG-CSF and GM-CSF in Neutropenia
Mehta, H. M., Malandra, M., & Corey, S. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500861 · Cited by 363
Metadata
- Authors
- Bonilla, M. A., Dale, D., Zeidler, C., Last, L., Reiter, A., Ruggeiro, M., Davis, M., Koci, B., Hammond, W., Gillio, A., & Welte, K.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1994-12
- Volume
- 88
- Issue
- 4
- Pages
- 723-730
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2024016372
- Cited by
- 205
- References
- 0
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias. https://app.cochat.ai/papers/10.1111/j.1365-2141.1994.tb05110.x
- The paper
- Bonilla, M. A., Dale, D., Zeidler, C., Last, L., Reiter, A., Ruggeiro, M., Davis, M., Koci, B., Hammond, W., Gillio, A., & Welte, K. (1994). Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1994.tb05110.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.